Endologix Honors Innovators of Aortic Therapy at VEITHsymposium
ENDOLOGIX (ELGX)
Last endologix earnings: 2/19 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.endologix.com
Company Research
Source: Business Wire
IRVINE, Calif.--(BUSINESS WIRE)-- Endologix, Inc. (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today honored four innovators of aortic therapy at the 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium®), a meeting of endovascular specialists highlighting developments in the treatment of vascular disease. At an event called “Learning from the Past to Shape the Future: Evolution of Aortic Therapy,” Endologix recognized the surgeons who advanced aortic repair therapy and initiated early randomized controlled trials of endovascular aneurysm repair (EVAR). Prior to the early 1990s, patients who were not eligible for open surgical repair were left untreated until early innovators challenged the status quo and developed endovascular grafts. “Randomized controlled trials are the gold standard for evaluating any t
Show less
Read more
Impact Snapshot
Event Time:
ELGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELGX alerts
High impacting ENDOLOGIX news events
Weekly update
A roundup of the hottest topics